Detalles de la búsqueda
1.
Diagnosis and management of gastric-type endocervical adenocarcinoma: A case report and review of the literature.
Gynecol Oncol
; 185: 165-172, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428332
2.
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Gynecol Oncol
; 183: 78-84, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554477
3.
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol
; 185: 186-193, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447347
4.
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Gynecol Oncol
; 182: 51-56, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262238
5.
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Gynecol Oncol
; 187: 105-112, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759516
6.
Assessment of socioeconomic and racial differences in patients undergoing concurrent gynecologic oncology and urogynecology surgeries: a National Inpatient Sample (NIS) database study.
Int J Gynecol Cancer
; 34(5): 751-759, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38719274
7.
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer.
Int J Gynecol Cancer
; 34(4): 469-477, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101816
8.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060236
9.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123694
10.
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.
Gynecol Oncol
; 175: 32-40, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321153
11.
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer.
Gynecol Oncol
; 175: 142-155, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385068
12.
"More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
Gynecol Oncol
; 175: 81-87, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329872
13.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol
; 170: 241-247, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736157
14.
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Gynecol Oncol
; 177: 46-52, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639902
15.
Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubbles.
Gynecol Oncol
; 173: 138-150, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178671
16.
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Gynecol Oncol
; 172: 82-91, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001446
17.
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Gynecol Oncol
; 173: 15-21, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37037083
18.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Gynecol Oncol
; 178: 14-22, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741201
19.
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population.
Gynecol Oncol
; 170: 203-209, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709661
20.
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Gynecol Oncol
; 178: 161-169, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890345